[1]GILLET JP,ANDERSEN JB,MADIGAN JP,et al.A gene expression signature associated with overall survival in patients with hepatocellular carcinoma suggests a new treatment strategy[J].Mol Pharmacol,2016,89(2):263-272.
|
[2]PENG H,LI QL,HOU SH,et al.Association of genetic polymorphisms in CD8+T cell inhibitory genes and susceptibility to and progression of chronic HBV infection[J].Infect Genet Evol,2015,36:467-474.
|
[3]THOLEY DM,AHN J.Impact of hepatitis C virus infection on hepatocellular carcinoma[J].Gastroenterol Clin North Am,2015,44(4):761-773.
|
[4]CHEN S,WANG Y,RUAN W,et al.Reversing multidrug resistance in hepatocellular carcinoma cells by inhibiting extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activity[J].Oncol Lett,2014,8(5):2333-2339.
|
[5]HO CT,SHANG HS,CHANG JB,et al.Folate deficiency-triggered redox pathways confer drug resistance in hepatocellular carcinoma[J].Oncotarget,2015,6(28):26104-26118.
|
[6]ZHENG W,SAI W,YAO M,et al.Silencing clusterin gene transcription on effects of multidrug resistance reversing of human hepatoma Hep G2/ADM cells[J].Tumour Biol,2015,36(5):3995-4003.
|
[7]DONG ZZ,YAO M,WANG L,et al.Abnormal expression of insulin-like growth factor-Ⅰreceptor in hepatoma tissues and its inhibition promoting apoptosis of tumor cells[J].Tumor Biol,2013,34(6):3397-3405.
|
[8]YAO NH,YAO DF,DONG ZZ,et al.Effects of inhibited IGF-ⅠR expression on proliferation and apoptosis of human hepatocellular carcinoma cell lines[J].Chin J Hepatol,2013,21(5):376-380.(in Chinese)姚宁华,姚登福,董志珍,等.足叶苦素抑制IGF-ⅠR表达对肝癌细胞增殖与凋亡的影响[J].中华肝脏病杂志,2013,21(5):376-380.
|
[9]YAO M,YAN XD,WANG L,et al.Down-regulating insulinlike growth factor-Ⅰreceptor gene transcription on effect of hepatoma growth inhibition[J].Chin J Cancer Prev Treat,2015,22(19):1528-1533.(in Chinese)姚敏,严晓娣,王理,等.干扰IGF-ⅠR基因表达对肝癌细胞裸鼠移植瘤生长影响研究[J].中华肿瘤防治杂志,2015,22(19):1528-1533.
|
[10]CHANG TS,WU YC,CHI CC,et al.Activation of IL6/IGFⅠR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression[J].Clin Cancer Res,2015,21(1):201-210.
|
[11]XIANG Y,LIU Y,YANG Y,et al.A secretomic study on human hepatocellular carcinoma multiple drug-resistant cell lines[J].Oncol Rep,2015,34(3):1249-1260.
|
[12]ZHAO X,CHEN Q,LI Y,et al.Doxorubicin and curcumin codelivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice[J].Eur J Pharm Biopharm,2015,93:27-36.
|
[13]FANTAPPIE O,SASSOLI C,TANI A,et al.Mitochondria of a human multidrug-resistant hepatocellular carcinoma cell line constitutively express inducible nitric oxide synthase in the inner membrane[J].J Cell Mol Med,2015,19(6):1410-1417.
|
[14]XIANG QF,ZHANG DM,WANG JN,et al.Cabozantinib reverses multidrug resistance of human hepatoma Hep G2/adr cells by modulating the function of P-glycoprotein[J].Liver Int,2015,35(3):1010-1023.
|
[15]YAN J,ZHOU Y,CHEN D,et al.Effects of mitochondrial translocation of telomerase on drug resistance in hepatocellular carcinoma cells[J].J Cancer,2015,6(2):151-159.
|
[16]CHENG L,LUO S,JIN C,et al.FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway[J].Cell Death Dis,2013,4:e923.
|
[17]YAN F,BAI LP,GAO H,et al.EGF reverses multi-drug resistance via the p-ERK pathway in Hep G2/ADM and SMMC7721/ADM hepatocellular carcinoma models[J].Asian Pac J Cancer Prev,2014,15(6):2619-2623.
|
[18]WANG PP,XU DJ,HUANG C,et al.Reversal of human hepatic cancer multidrug resistance is induced by astragalosideⅡin BEL-7402/FU cells[J].Chin J Clin Pharmacol Ther,2014,19(2):139-144.(in Chinese)王培培,许杜娟,黄灿,等.黄芪皂苷Ⅱ对人肝癌多药耐药细胞BEL-7402/FU的逆转耐药作用[J].中国临床药理学与治疗学,2014,19(2):139-144.
|
[19]SHEN J,SUN H,MENG Q,et al.Simultaneous inhibition of tumor growth and angiogenesis for resistant hepatocellular carcinoma by co-delivery of sorafenib and survivin small hairpin RNA[J].Mol Pharm,2014,11(10):3342-3351.
|